# A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.

> **NCT00577109** · PHASE2 · WITHDRAWN · sponsor: **Hoffmann-La Roche**

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** bevacizumab [Avastin]
- **DRUG:** Irinotecan
- **DRUG:** Leucovorin
- **DRUG:** 5 FU
- **DRUG:** Cetuximab

## Key facts

- **NCT ID:** NCT00577109
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-12
- **Primary completion:** 2012-06
- **Final completion:** 2012-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study was cancelled before patient enrollment
- **Last updated:** 2018-07-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00577109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00577109, "A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00577109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*